KRAS and neoplasm: Although KRAS status did not correlate with pathological T factors, mean tumor diameter was larger in patients with KRAS mutations (3.46 ± 1.99 cm) than in those with wild-type KRAS (2.99 ± 1.36 cm; P = 0.001).